8-K
filed May 7, 2024, 7:59 PM ET
ticker INSP
CIK 0001609550
earnings
confidence high
sentiment positive
materiality 0.85
Inspire Medical Q1 revenue $164M (+28% YoY); raises FY2024 guidance, expects full-year profitability
Inspire Medical Systems, Inc.
2024-Q1 EPS reported
-$0.34
revenue$164,010,000
- Q1 2024 revenue $164.0M, up 28% YoY; net loss narrowed to $10.0M ($0.34/share) from $15.4M.
- U.S. revenue $155.8M (+25% YoY); OUS revenue $8.2M (+141%); gross margin 84.9% vs 84.4%.
- FY2024 revenue guidance raised to $783-793M (25-27% growth); first-time diluted EPS guidance $0.10-$0.20.
- Added 66 new U.S. centers (total 1,246) and 11 new sales territories (total 298) in Q1.
- Ended Q1 with $469.2M cash; expects full-year 2024 profitability.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Inspire Medical Systems, Inc. reported the full year 2024 results: revenue $783 million to $793 million. Guidance raised.
- Period
- the full year 2024
- Revenue
- $783 million to $793 million
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
Inspire is initiating first-time diluted net income per share guidance for the full year 2024 of between $0.10 to $0.20 per share.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Inspire Medical Systems, Inc. reported the full year 2024 results: revenue $783 million to $793 million. Guidance raised.
- Period
- the full year 2024
- Revenue
- $783 million to $793 million
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
Inspire is increasing its full year 2024 revenue guidance to between $783 million to $793 million, which represents growth of 25% to 27% over full year 2023 revenue of $624.8 million.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Inspire Medical Systems, Inc. reported the quarter ended March 31, 2024 results: revenue $164.0 million, net income $10.0 million net loss, EPS $0.34 per share net loss per share.
- Period
- the quarter ended March 31, 2024
- Revenue
- $164.0 million
- Net income
- $10.0 million net loss
- EPS
- $0.34 per share net loss per share
- Result
- reported results
Exact text from the filing
Revenue was $164.0 million for the three months ended March 31, 2024, a 28% increase from $127.9 million in the corresponding period in the prior year.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.